| abstract |
According to one aspect there is provided a purine compound, a stereoisomer, derivative, solvate, or pharmaceutically acceptable salt thereof, a process for its preparation, and uses thereof. Accordingly, the above compound, its stereoisomer, derivative, solvate, or pharmaceutically acceptable salt thereof has low cytotoxicity, selectively high inhibitory activity against HSP90, and antiproliferative effect of cancer cells, Or can be used therapeutically. |